Dr Neil Shastri-Hurst
MP for Solihull West and Shirley · Conservative · United Kingdom
“A consequence of having a plan for a road map to 3% of GDP is that there is no strategy whatsoever. I am afraid that the absence of that plan, from this particular Chancellor especially, does nothing to enhance his credibility in front of the British public and the markets. The second area, which I will touch on briefly, is welfare.”
House of Commons29 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“It is a pleasure to follow the hon. Member for Edinburgh East and Musselburgh (Chris Murray), although I suspect that we will have slightly different assessments of this Budget.”
House of Commons29 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“I am one of those individuals, from my historical earnings at the Bar and my aged debt. Under the new proposal, individuals will pay their taxes perhaps on a monthly or quarterly basis—it is unclear yet—and some 50% of tax returns will almost certainly be brought forward in terms of when they are paid.”
House of Commons29 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Thank you, Mr Speaker. May I start by associating myself with your remarks on the tragic events involving Helen Haines over the last 24 hours?”
House of Commons20 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“It described young carers as “one of the least visible groups in the NEET conversation and one of the most systematically miscounted.” A young person who misses college, declines an apprenticeship interview or struggles to attend a job or university may be managing responsibilities that somebody has simply not asked about.”
House of Commons15 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“That risks leaving the carer carrying entirely the same burden and responsibility as they had beforehand, but with less confidence that if they ask in the future it will make an iota of difference, and consequently, potentially, with declining physical and mental wellbeing.”
House of Commons15 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
The complete record
645 held · 618 searchable for Dr Neil Shastri-Hurst. The searchable lines are below in date order, each linked to its source. Free to read, in full, without an account. Page 2 of 10.
This is not an official version of UK Parliament proceedings. It reproduces the published record and links to it; the official version is the one UK Parliament publishes.
“Our responsibility is to the British public, and that means telling them the truth. As we have heard repeatedly during the course of today, the truth is that the world has changed and the threats are very real. For far too long, we have risked treating defence as something done by someone else—something done by sailors under the waves, soldiers on distant deployments and pilots in the skies. However, modern deterrence asks us to do much more individually. It also requires government to be honest, and the public to understand what is really at stake. As we have heard, the Government have clearly set out that Russia could be in a position to attack a NATO ally by as early as the end of this decade.”
House of Commons8 July 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“I refer Members to my entries in the Register of Members’ Financial Interests, in particular my participation in a parliamentary delegation to Ukraine in February with the UK friends of the armed forces. [ Official Report , 14 July 2026; Vol. 789, c. 12WC.] (Correction) I want to build on some of the arguments made by the hon. Member for Dunfermline and Dollar (Graeme Downie). As I sat here listening to this thoughtful and valuable debate, the issue that really struck me above anything else was that, in many ways, we are preaching to the converted in this Chamber. Those of us who are here recognise the seriousness of the moment—we understand that defence is not an optional extra and that it cannot wait for a more convenient fiscal moment—but our responsibility goes much further than this Chamber, of course.”
House of Commons8 July 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“I have a great deal of respect for the Minister, and he has adopted the tone of the House, which is united on tackling this issue; but there is clearly a lacuna in the law as it stands. It will take time, however fast the Government work, to get that change on the statute books. In the interim, is the Minister prepared to use sanctions against Pakistan to ensure the deportation of this grievous individual?”
House of Commons6 July 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“In response to the DIP, the noble Lord Hutton, a former Labour Defence Secretary, said that “the centres of resistance across Whitehall to extra defence spending have been allowed to prosper and they haven’t been overcome.” He went on to say that, as a consequence, our armed forces will not be war-ready by the end of this Parliament. Does the Defence Secretary disagree with the noble Lord? How do the £10.7 billion in cuts to the MOD budget enhance our armed forces’ readiness?”
House of Commons30 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“There are now over 1 million young people not in education, employment or training, which is the highest number in more than a decade. When the history books are written on this period of Government, does the Secretary of State agree that the story will be of a lost generation?”
House of Commons29 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Space has a crucial role to play in our national resilience. Responsibility for it cuts across Government Departments. With that in mind, and given the Cabinet Office’s role in cross-Government co-ordination, can the Minister confirm when the National Space Council will next convene?”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“T2. Indeed—I am back by popular demand.Will the Minister set out what steps the Cabinet Office is taking to ensure that public appointments are made on merit alone and not based on political patronage or ideological principles?”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“This brutal conflict has resulted in more than 14 million people being displaced. Around 5 million of those have been displaced over the border, but 9 million are displaced in Sudan itself. Will the Minister set out what practical steps the Government are taking to support those who are displaced internally?”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“There will be different views on the evidence, on treatment and on guidance, but there should be no difference between us on the need for children to be seen, for families to be heard, for clinicians to be supported, and for care to be based on evidence, rather than the accident of geography. For families living with PANS/PANDAS, progress will be measured by whether the next family gets an earlier answer, whether the next child is believed sooner, whether the next GP has somewhere to turn, and whether the next school understands. That is a fair and compassionate standard, and it is the one that the Government should now meet.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“With that in mind, I would appreciate the Minister setting out how the Government intend to support that work and encourage greater patient involvement. There is also a need for greater consistency across local systems. If support is left entirely to local discretion, care will depend on where a family lives or how hard they are able to fight for it. Clearer information on how suspected cases can be supported across specialties should be available to ICBs, and schools also have to be part of the answer. For many families, school is where the change is first noticed; better awareness of sudden onset and fluctuating symptoms could help ensure sensible attendance policies and flexible, rapid and responsive classroom adjustments. This debate should not be one that divides the House, but one that unites it.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Will she commit to a clear process for assessing emerging evidence? We also need to take action on professional awareness. I recall reading about these conditions in Kumar & Clark when I was a medical student, but I do not recall receiving any formal training on them. It is not enough to ask our clinicians to be responsible for keeping their knowledge up to date; atypical, complex and contested conditions require practical support. As such, I ask the Minister to consider an awareness package for frontline professionals, developed in conjunction with clinicians, families and experts. We also need action on data and research—we need better data, diagnostic clarity, and research into treatment and long-term outcomes.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Families do not experience this as a framework, action plan or written answer; they experience it as the moment when a child refuses food, compulsions appear, school attendance collapses or a parent is told that a professional has never heard of the condition. If the problem is complexity, inconsistency and a lack of recognition, the solution must be equal in its seriousness. The foundations have been set, and now we must all go further. We need action on guidance. The clinical guidance being developed by PANS PANDAS UK and the PANS guideline development group brings together expertise from general practice, paediatrics, neurology, immunology, infectious diseases, psychiatry, psychology and nursing. I would be grateful if the Minister could set out how the Government will engage with that guidance once it is published.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The previous Government did not solve this issue, but foundations were laid through the UK rare diseases framework, annual action plans and engagement with research, including with the APPG and the working group. The current Government have welcomed clinical guidance being developed by PANS PANDAS UK and have said that NICE will consider national guidance as evidence improves. They have also pointed to NIHR research and extended the rare diseases framework into 2027. Where the Government do the right thing, we should welcome it, but the question is whether those actions are sufficient. Do they need to go faster? Are they reaching the families on the ground?”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The NHS is still too often structured around separate silos, whether it is mental health, neurology, infectious disease, immunology or paediatrics, but children living with these conditions do not arrive in neat administrative categories; their needs are complex, sudden and overlapping. That makes it hard for families to know where to turn, as well as for clinicians who want to help but may not have had the training to do so, and for schools that see a child’s behaviour change dramatically without understanding what is driving it. We must also be candid about the emotional difficulty. Parents can feel dismissed. They can feel treated as difficult or seen as overanxious when they are simply trying to explain what has happened to their child. No child should be left waiting for help because the system is unsure about where they fit.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The Government have said that data on the number of children affected is not currently collected, because internationally the criteria cannot be agreed. Local integrated care systems are expected to plan services, but they are asked to do so without consistent national direction, which risks variation. As we have heard, in reality variation leads to a postcode lottery. It means that one family may find an informed GP, paediatrician or neurologist, while another family is left scrambling for help. It means that one school may understand the sudden onset and fluctuating need, while another school sees only challenging behaviour. It means that one parent may feel believed, while another parent feels blamed. That is the difficulty at the heart of this debate. PANS/PANDAS cut across the way our systems are organised.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The problem is not that every scientific question has been answered, because clearly it has not. There is uncertainty and professional disagreement, and there is a need for stronger evidence, better data and more research into diagnosis, treatment and long-term outcomes. However, uncertainty has too often translated into inconsistency. It has meant too many families left without a clear answer, too many clinicians left without guidance, too many schools unsure of how to respond and too many children caught between services. Each see part of the picture, but they do not see the child as a whole. At present, there is no official NHS clinical guidance for the diagnosis and treatment of PANS/PANDAS. NICE has previously concluded that the evidence was insufficient to provide useful guidance.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“They include obsessive-compulsive behaviours, restricted eating, tics, anxiety, behavioural change, sleep disturbance, regression, movement difficulties, school refusal and distress that can overwhelm the entire family. For some families, the story is stark. A child who was settled and sociable becomes frightened, withdrawn and unable to eat. A child who was thriving at school begins to struggle. Families find themselves moving from GPs to child and adolescent mental health services, from paediatrics to emergency departments, and from school meetings to safeguarding conversations, often without a clear pathway or a clinician who is able to say, “Do you know what? I recognise this, and this is what we need to do next.” The first task before us is to diagnose the problem honestly.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“For them, this is not an abstract discussion about guidance, systems or clinical pathways; it is about the child they love, the moment something changed and the exhaustion of trying to explain that change to people who may never have heard of the condition before. It is about parents who overnight become advocates, researchers, case managers and campaigners, while simultaneously trying to hold their families together, and about the children and young people whose lives can be altered suddenly and terrifyingly. As we have heard, PANS/PANDAS sit at the intersection of neurology, psychiatry, immunology and infectious diseases. That matters because they do not fit neatly into one service, specialty, clinic or budget line. For the children affected, symptoms can be sudden and severe.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“He talked about the excellent campaigning by Albie, who is in the Gallery today, following his brother’s diagnosis—I suspect Albie’s handwriting is somewhat better than my doctor’s scrawl and I commend him on his campaigning. The hon. Member for Harlow (Chris Vince), who is always keen to speak up and champion issues on behalf of his constituents, spoke about the importance of guidance. My right hon. Friend the Member for New Forest East (Sir Julian Lewis) talked about the importance of the early use of antibiotics. Above all, I want to speak directly to the families and children who are following the debate and who live with PANS/PANDAS every day, some of whom are with us in the Gallery today.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“It is a privilege to respond to the debate on behalf of His Majesty’s loyal Opposition. I pay tribute to the hon. Member for North East Fife (Wendy Chamberlain) for securing the debate and for setting out the landscape facing those with PANS/PANDAS in the UK, as well as recognising the lack of knowledge about the conditions and the challenge that presents. I thank her for her sustained work through the APPG on the issue. Many right hon. and hon. Members have contributed to the debate. The hon. Member for Carlisle (Ms Minns) spoke movingly about Joanne and Jake, who have been living with PANS/PANDAS for the past six years, and the challenges of not getting the treatment or the funding that they need. The hon. Member for Henley and Thame (Freddie van Mierlo) made a good point about how those affected do not want sympathy but action.”
House of Commons25 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“A soldier deployed on operations is not situated in the same circumstances as a civilian living in peacetime; the realities of combat are fundamentally different. Those of us who have had the privilege to spend time with serving personnel quickly come to appreciate that military operations are conducted in conditions of danger, ambiguity and enormous pressure. Decisions are often made in moments, not months. Commanders and soldiers do not enjoy the luxury of hindsight that is available to lawyers examining events years later from the cold comfort of a courtroom.”
House of Commons22 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“New clause 4 is not a radical proposition; it is a relatively modest measure that simply recognises commitment and rewards service. Crucially, it sends a clear signal that Parliament values not only those who wear the uniform but the families who stand behind them. Over the past two decades, there has been a considerable concern about the extent to which human rights litigation has affected military operations overseas. Parliament has recognised those concerns in previous legislation relating to overseas operations. That issue is not a novel one, but part of a continuing debate about how best to reconcile operational effectiveness, accountability and fairness. The argument for new clauses 9 and 11 is, at its heart, a simple one.”
House of Commons22 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“They have worn our uniform, accepted unlimited liability in defence of our national interests, and contributed directly to our security. In those circumstances it cannot be right, having honoured their commitment to our country, that we appear reluctant to honour our commitment to them. The armed forces covenant, as my right hon. and gallant Friend the Member for Rayleigh and Wickford (Mr Francois) mentioned, rests on the principle that those who serve should suffer no disadvantage as a result of that service. It is difficult to reconcile that principle with a situation in which a family that has supported a service member throughout years of deployments and postings, is then confronted with substantial costs in order to remain together in the country for which that service was given.”
House of Commons22 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“When we speak of supporting the armed forces, we cannot confine our attention solely to those in uniform; we must also consider the spouses and children who support them. New clause 4, tabled by my hon. and gallant Friend the Member for Huntingdon (Ben Obese-Jecty), addresses a concern that many Members across this House have heard repeatedly from serving personnel and veterans alike: that the financial burden imposed on families seeking indefinite leave to remain after years of loyal service to this country is too much. There is a straightforward question before us. If an individual has given years of service to our nation, why should their family then face significant financial barriers simply to secure their future here?”
House of Commons22 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“It therefore follows that the first duty of Parliament towards those who discharge that responsibility is to ensure that they are treated with fairness, dignity and respect. That means understanding that military service is not simply another profession, but a vocation that places demands on individuals and their families that most of our fellow citizens will never be asked to bear. I begin with new clause 4. I have long believed that when an individual commits to service in the armed forces, the nation enters a contract with them that carries practical consequences. We ask our service personnel to accept postings away from home, to move their families at short notice, to spend long periods separated from loved ones, and, in some cases, to place themselves in danger on our behalf.”
House of Commons22 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“I place on record that, as a veteran myself, it was a huge privilege to serve on the Select Committee that considered this important legislation. I will concentrate my remarks on new clauses 4, 9 and 11. At first glance, they may appear to concern different matters, yet, in reality, they are united by the common principle that Parliament should ensure that those who serve this country are treated fairly, and that the law recognises the unique obligations we place on them. We quite rightly celebrate the professionalism of our armed forces. We ask them to defend our interests overseas, deter our adversaries, and, when necessary, place themselves between danger and the rest of us. It is right that the first duty of any Government is the defence of our realm.”
House of Commons22 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The Minister is right to point to the uncertainty that businesses are facing, and my constituents and local businesses repeat that message to me regularly. The Minister has indicated that there may be a chance that some of the tariffs or the categorisations will be changed. Will he undertake to come to the House and make a statement as soon as that is announced?”
House of Commons17 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“It is a pleasure to serve under your chairmanship this evening, Mrs Barker. I am grateful to the hon. Member for Colne Valley (Paul Davies) for opening this important debate, and to other right hon. and hon. Members for their contributions to it. I also pay tribute to Brain Cancer Justice and to all the people—over 109,000 in total—who signed this petition to ensure that we have had the opportunity to debate this important issue here today. At its heart, this debate has been about the patients, families and loved ones whose lives have been irreparably changed by a brain tumour diagnosis. For many families, of course, that diagnosis arrives suddenly, although too often it is also delayed.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Behind every statistic is a person and behind every policy discussion is a family desperately hoping for more time. Today, I want to particularly recognise the courage of those families whose stories have been shared, often while living through the most unimaginable grief, so that others might one day have a better chance. I also want to pay tribute to the remarkable charities, researchers, clinicians and campaigners who have worked tirelessly to keep this issue on the national agenda: organisations such as the Brain Tumour Charity, Tessa Jowell Brain Cancer Mission, Brain Tumour Research, Cancer Research UK and countless others that have not only supported patients and families, but have driven forward research, awareness and innovation.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“I am very grateful to my hon. Friend for sharing Holly’s story, which sadly, is far too frequent. I remember from my time in clinical practice that those subtle signs were sadly sometimes missed. We need to do much more to ensure that our clinicians are aware of them so that they can make an early diagnosis. Of course, when those diagnoses arrive, it is inevitably devastating. It turns lives upside down in an instant. Parents are told that their child has a condition with few treatment options, husbands and wives are forced to confront an uncertain future and children become carers. Families who should be planning birthdays, holidays and life milestones instead find themselves navigating endless hospital corridors, scans and treatments.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Genome sequencing has enormous potential to improve the understanding of tumour biology, identify personalised treatment pathways and increase participation in clinical trials. However, opportunities remain unevenly distributed across the country. The Brain Tumour Charity has also highlighted significant variations in infrastructure and staffing across neuro-oncology centres.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“I would therefore be grateful if the Minister could update us on what progress has been made in establishing the new structures required under the Rare Cancers Act. In particular, has the national specialty lead been appointed? When will the rare cancer registry become fully operational? How will success be measured? Patients and families deserve to know when they will begin to see tangible benefits from the legislation that Parliament has passed. The petition also raised important questions about research participation and access to innovation. The Tessa Jowell Brain Cancer Mission highlighted that fewer than 5% of eligible adult brain tumour patients were able to access whole-genome sequencing because of limitations in tissue sampling and biobanking capacity, which is deeply concerning.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The establishment of the national speciality lead and a dedicated cancer registry service have the potential to improve co-ordination and data collection and strengthen research. The national cancer plan has recognised rare cancers as a priority area and committed to expanding successful models such as the Tessa Jowell Brain Cancer Mission. Those developments are of course all welcome. As His Majesty’s loyal Opposition, we supported the Rare Cancers Act throughout its passage through Parliament because we recognise that patients with rare cancers deserve the same urgency, focus and ambition as those with more common conditions. However, the reality is that legislation alone does not save lives; the real test is the effectiveness of its implementation.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Quite rightly, the petition calls for greater investment in research, wider access to whole-genome sequencing and stronger support for innovative treatments. Those are priorities that cannot be ignored any longer. However, before I turn to those challenges, I want to take a moment to acknowledge the progress that has been made. The National Institute for Health and Care Research has established the brain tumour research consortium, which has brought together dozens of organisations to co-ordinate research and is backed by up to £25.5 million of investment. The recently enacted Rare Cancers Act 2026 represents another significant step forward, and I want to commend the hon. Member for Edinburgh South West (Dr Arthur) for his work in bringing that legislation on to the statute book.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The hon. Gentleman is absolutely right. There are countless charities that have done a huge amount of work, and what they are doing is making a tangible difference to people’s lives. Sadly, brain tumours remain one of the most challenging forms of cancer. In many instances, outcomes are no better than when I worked as a doctor in neurosurgery almost a decade and a half ago. The less survivable cancers taskforce has highlighted that one-year survival rates for less survivable cancers, which include brain cancers, remain significantly lower than the average across all cancers. Despite advances in medicine, outcomes for many patients have not improved at the pace that we would all wish to see. That is why the concerns raised by the petitioners are so important.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“With every breakthrough that provides a scientific curiosity, the challenge before us as a Government, as an Opposition and as clinicians and researchers is to ensure that those breakthroughs happen more quickly and often, so that they can reach patients quicker. That is what the families behind this petition are seeking, and they deserve no less.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“For all the challenges that we have discussed today, it is important that we recognise the reasons for hope. Medical research continues to achieve what once seems impossible. Just a few years ago, diffuse intrinsic pontine glioma was regarded as one of the most devastating childhood brain cancers, with very few children surviving beyond two years. However, through participation in innovative clinical trials, a young boy from Belgium named Lucas Jemeljanova experienced something quite extraordinary. Having been diagnosed at six, he entered the trial and, over time, scans showed a shrinking tumour, which eventually disappeared altogether. Lucas is now 13, and he is considered cured.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The Office for Budget Responsibility has estimated that increasing spending on branded medicines will carry significant costs over the coming years, so can the Minister explain how the Government intend to fund those commitments? Patients need confidence that the announcements we hear today will be translated into treatments tomorrow. Similarly, while we welcome the publication of the national cancer plan earlier this year, questions remain about its implementation. The shadow Health and Social Care Secretary, my right hon. Friend the Member for Daventry (Stuart Andrew), supported the ambitions set out within the plan. However, he quite rightly called for clear, funded milestones, and those questions remain unanswered. When will the Government publish measurable targets for rare cancers, and how will progress be reported?”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Such hope is entirely understandable, but at the same time we must maintain rigorous standards of safety and evidence. The challenge for us as policymakers is not choosing between innovation and safety; it is ensuring that innovation can be assessed, trialled and adopted as quickly as possible, when the evidence supports it. That is why clinical research capacity and trial recruitment matter so much, and it is why access to cutting-edge treatments must remain a key priority. On that point, the Government have committed to increase spending on branded medicines, and they have set out ambitious objectives for expanding participation in commercial clinical trials. Of course those ambitions are welcome, but they must be matched by delivery.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The hon. Lady is absolutely right that when someone is facing a devastating crisis, but has to travel excessive distances to get the treatment they deserve, there is something wrong with the system. If we are serious about accelerating research, we must ensure that every patient has a fair opportunity to participate in it. That requires investment not only in laboratories and technology, but in a workforce that supports research and clinical innovation. What specific action are the Government taking to address those disparities and ensure that advances in research can benefit patients regardless of where they live? The petition also reflects a wider frustration felt by many families facing brain cancer. When conventional options are exhausted, patients understandably look to emerging treatments and clinical trials with hope.”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Last week, the former Defence Secretary said that the Prime Minister was unable and the Chancellor unwilling to fund the resources needed to tackle the threats facing our nation. Does the Minister agree with that assessment, and if not, why not?”
House of Commons15 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“I listened carefully to the Minister’s response to my hon. Friend the Member for Broadland and Fakenham (Jerome Mayhew), but the reality is that every day shopkeepers are facing abuse and threats and being stolen from. A direct consequence of the presumption in the Sentencing Act 2026 that those with a sentence of 12 months or less will not face prison is that there is no deterrent. Can the Minister genuinely say that our streets are safer as a result?”
House of Commons8 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Imagine a scenario in which two individuals are both charged with the same offence and the factual matrix of each case is identical. However, the first defendant has a string of previous convictions, whereas the second has none. Under the Government’s proposal, the first defendant would be able to elect for a jury trial, depending on the length of the potential sentence, whereas the second would not. How does that align with the Solicitor General’s assessment of the rule of law?”
House of Commons4 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The Government’s constant refrain is that they are “working at pace”, but the reality is that our adversaries are doing exactly that. In an increasingly unstable world, the lack of a defence readiness Bill is a significant disadvantage. Will the Minister set out when the Bill will be published, and the specific date on which it will come before the House?”
House of Commons1 June 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“T8. I think it is fair to say that the Government and I do not see eye to eye when it comes to the policy of curtailing trial by jury. However, if the Government are determined to go down that route, their own impact assessment sets out that a significant number of magistrates need to be recruited—the MOJ has put it at 7,000 over three years. In order for the Government’s own plan to work, will they commit not to change any of the rules around trial by jury until they have recruited those magistrates?”
House of Commons19 May 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Phoenix shops are a blight on many of our high streets, including in my constituency of Solihull West and Shirley. Councillor Karen Grinsell, the leader of Solihull metropolitan borough council, recently brought forward a motion to have greater statutory powers to close down these stores. Will the Leader of the House provide Government time to debate this issue so that we can close these stores for good?”
House of Commons23 April 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Quis custodiet ipsos custodes? As the Prime Minister will know, that means “Who guards the guards themselves?” With that in mind, and on the subject of holding those in power to account, can he explain why he took almost a week to come to this House, when the public will have been expecting answers much sooner?”
House of Commons20 April 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“For many, though, it is something much more practical: what happens if we become too reliant on a single provider for something as critical as health data infrastructure? I think that is a fair question. However, we should also separate those questions from the broader argument about the company’s international work. In a global economy, companies will inevitably work with different Governments, and that alone is not a sufficient reason to exclude them from public contracts in the UK. The question of procurement design, competition and resilience, however, is a different matter.”
House of Commons16 April 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“Those are not unreasonable questions; they are the natural questions people ask when large new systems are created. Again, I ask the Minister what more will be done to reassure the public about the limits of how NHS data can be used and whether he can set out clearly where parliamentary oversight comes in if the use of data is expanded in the future. Trust is not built by reassurance alone; it is built by clarity and restraint. A significant part of this debate has understandably focused on Palantir, and it is right that it has. Palantir is now a major supplier within the NHS data infrastructure as well as elsewhere across Government, and that raises legitimate questions about not just capability but dependence. For some the concern is political, while for others it is about principle.”
House of Commons16 April 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“People are right to care about their medical data—it is sensitive, personal and deeply private. Once confidence is lost in this area, it is very difficult to rebuild it. There are important safeguards in place: the data remains under NHS control, the access is tightly regulated, and the provider does not own or use the data for its own purposes. The legal framework underpinning those safeguards is strong. Those are not minor points—they really matter. However, we also have to recognise something else. People are not just asking whether the system is safe today, but what it enables tomorrow. Could the data be combined in ways that reveal more than people expect? Could systems evolve in ways not originally intended? Could future Governments choose to use the capability in different ways?”
House of Commons16 April 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗